Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease

Kidney International

Volumn 85, Issue 6, 2014, Pages 1340-1350

  Spichtig, Daniela ^a   Zhang, Hongbo ^a   Mohebbi, Nilufar ^a,b   Pavik, Ivana ^a   Petzold, Katja ^a   Stange, Gerti ^a   Saleh, Lanja ^b   Edenhofer, Ilka ^a   Segerer, Stephan ^a,b   Biber, Jürg ^a   Jaeger, Philippe ^c   Serra, Andreas L ^a,b   Wagner, Carsten A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

FGF23; phosphate; polycystic kidney disease

Indexed keywords

CALCITRIOL; CALCIUM; CREATININE; FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR SUBSTRATE 2ALPHA; KLOTHO PROTEIN; MESSENGER RNA; PHOSPHATE; SODIUM PHOSPHATE COTRANSPORTER 2A; SODIUM PHOSPHATE COTRANSPORTER 2C; UNCLASSIFIED DRUG; UREA; BETA GLUCURONIDASE; BIOLOGICAL MARKER; FGF23 PROTEIN, RAT; FIBROBLAST GROWTH FACTOR; FIBROBLAST RECEPTOR SUBSTRATE 2, RAT; PARATHYROID HORMONE; POLYCYSTIC KIDNEY DISEASE 1 PROTEIN; POLYCYSTIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BONE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; KIDNEY POLYCYSTIC DISEASE; MALE; MOUSE; NONHUMAN; PHOSPHATE BLOOD LEVEL; PHOSPHATE EXCRETION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVIEW; SPLEEN; UREA BLOOD LEVEL; VITAMIN METABOLISM; ANIMAL; BLOOD; DEFICIENCY; DISEASE MODEL; GENETICS; KIDNEY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BIOLOGICAL MARKERS; CALCITRIOL; CALCIUM; CREATININE; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; KIDNEY; MALE; MICE, KNOCKOUT; PARATHYROID HORMONE; PHOSPHATES; PHOSPHORYLATION; POLYCYSTIC KIDNEY DISEASES; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRPP CATION CHANNELS; UP-REGULATION; UREA;

EID: 84901913047     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.526     Document Type: Article

References (57)

1. Bacic D, Capuano P, Baum M et al. Activation of dopamine D1-like receptors induces acute internalization of the renal Na\+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells. Am J Physiol Renal Physiol 2005; 288: F740-F747.
2. Bacic D, Lehir M, Biber J et al. The renal Na\+/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone. Kidney Int 2006; 69: 495-503.
3. Baum M, Schiavi S, Dwarakanath V et al. Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules. Kidney Int 2005; 68: 1148-1153.
4. Berndt TJ, Bielesz B, Craig TA et al. Secreted frizzled-related protein-4 reduces sodium-phosphate co-transporter abundance and activity in proximal tubule cells. Pflugers Arch 2006; 451: 579-587.
5. Biber J, Hernando N, Forster I et al. Regulation of phosphate transport in proximal tubules. Pflugers Arch 2009; 458: 39-52.
6. Capuano P, Radanovic T, Wagner CA et al. Intestinal and renal adaptation to a low-Pi diet of type II NaPi cotransporters in vitamin D receptor-and 1alphaOHase-deficient mice. Am J Physiol Cell Physiol 2005; 288: C429-C434.
7. Murer H, Hernando N, Forster I et al. Proximal tubular phosphate reabsorption: molecular mechanisms. Physiol Rev 2000; 80: 1373-1409.
8. Murer H, Hernando N, Forster I et al. Regulation of Na/Pi transporter in the proximal tubule. Annu Rev Physiol 2003; 65: 531-542.
9. Picard N, Capuano P, Stange G et al. Acute parathyroid hormone differentially regulates renal brush border membrane phosphate cotransporters. Pflugers Arch 2010; 460: 677-687.
10. Nowik M, Lecca MR, Velic A et al. Genome-wide gene expression profiling reveals renal genes regulated during metabolic acidosis. Physiol Genomics 2008; 32: 322-334.
11. Yamashita T, Yoshioka M, Itoh N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 2000; 277: 494-498.
12. Liu S, Guo R, Simpson LG et al. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 2003; 278: 37419-37426.
13. Shimada T, Hasegawa H, Yamazaki Y et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004; 19: 429-435.
14. Urakawa I, Yamazaki Y, Shimada T et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006; 444: 770-774.
15. Farrow EG, Davis SI, Summers LJ et al. Initial FGF23-mediated signaling occurs in the distal convoluted tubule. J Am Soc Nephrol 2009; 20: 955-960.
16. Olauson H, Lindberg K, Amin R et al. Targeted deletion of klotho in kidney distal tubule disrupts mineral metabolism. J Am Soc Nephrol 2012; 23: 1641-1651.
17. Andrukhova O, Zeitz U, Goetz R et al. FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2-SGK1 signaling pathway. Bone 2012; 51: 621-628.
18. Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218.
19. Shigematsu T, Kazama JJ, Yamashita T et al. Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis 2004; 44: 250-256.
20. Gutierrez O, Isakova T, Rhee E et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 2005; 16: 2205-2215.
21. Evenepoel P, Meijers B, Viaene L et al. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism. Clin J Am Soc Nephrol 2010; 5: 1268-1276.
22. Isakova T, Wahl P, Vargas GS et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011; 79: 1370-1378.
23. Pavik I, Jaeger P, Ebner L et al. Secreted Klotho and FGF23 in chronic kidney disease stage 1 to 5: a sequence suggested from a cross-sectional study. Nephrol Dial Transplant 2013; 28: 352-359.
24. Hasegawa H, Nagano N, Urakawa I et al. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int 2010; 78: 975-980.
25. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007; 369: 1287-1301.
26. Reeders ST, Breuning MH, Davies KE et al. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 1985; 317: 542-544.
27. Peters DJ, Spruit L, Saris JJ et al. Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease. Nat Genet 1993; 5: 359-362.
28. Kimberling WJ, Kumar S, Gabow PA et al. Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics 1993; 18: 467-472.
29. Hughes J, Ward CJ, Peral B et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 1995; 10: 151-160.
30. Mochizuki T, Wu G, Hayashi T et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996; 272: 1339-1342.
31. Pavik I, Jaeger P, Kistler AD et al. Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate. Kidney Int 2011; 79: 234-240.
32. Pavik I, Jaeger P, Ebner L et al. Soluble klotho and autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2012; 7: 248-257.
33. Bihoreau MT, Ceccherini I, Browne J et al. Location of the first genetic locus, PKDr1, controlling autosomal dominant polycystic kidney disease in Han:SPRD cy/\+ rat. Hum Mol Genet 1997; 6: 609-613.
34. Brown JH, Bihoreau MT, Hoffmann S et al. Missense mutation in sterile alpha motif of novel protein SamCystin is associated with polycystic kidney disease in (cy/\+) rat. J Am Soc Nephrol 2005; 16: 3517-3526.
35. Schäfer K, Gretz N, Bader M et al. Characterization of the Han:SPRD rat model for hereditary polycystic kidney disease. Kidney Int 1994; 46: 134-152.
36. Ahrabi AK, Jouret F, Marbaix E et al. Glomerular and proximal tubule cysts as early manifestations of Pkd1 deletion. Nephrol Dial Transplant 2010; 25: 1067-1078.
37. Torres VE, Bengal RJ, Litwiller RD et al. Aggravation of polycystic kidney disease in Han:SPRD rats by buthionine sulfoximine. J Am Soc Nephrol 1997; 8: 1283-1291.
38. Turner CM, Ramesh B, Srai SKS et al. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/\+ rat, a model of autosomal dominant polycystic kidney disease. Cells Tissues Organs 2004; 178: 168-179.
39. Wahl PR, Serra AL, Le Hir M et al. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). Nephrol Dial Transplant 2006; 21: 598-604.
40. Wu M, Arcaro A, Varga Z et al. Pulse mTOR inhibitor treatment effectively controls cyst growth but leads to severe parenchymal and glomerular hypertrophy in rat polycystic kidney disease. Am J Physiol Renal Physiol 2009; 297: F1597-F1605.
41. Vogel M, Kränzlin B, Biber J et al. Altered expression of type II sodium/phosphate cotransporter in polycystic kidney disease. J Am Soc Nephrol 2000; 11: 1926-1932.
42. Faul C, Amaral AP, Oskouei B et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011; 121: 4393-4408.
43. Piontek K, Menezes LF, Garcia-Gonzalez MA et al. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat Med 2007; 13: 1490-1495.
44. Bergwitz C, Jü ppner H. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 2010; 61: 91-104.
45. Marsell R, Krajisnik T, Gö ransson H et al. Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23. Nephrol Dial Transplant 2008; 23: 827-833.
46. Liu S, Vierthaler L, Tang W et al. FGFR3 and FGFR4 do not mediate renal effects of FGF23. J Am Soc Nephrol 2008; 19: 2342-2350.
47. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V et al. The parathyroid is a target organ for FGF23 in rats. J Clin Invest 2007; 117: 4003-4008.
48. Galitzer H, Ben-Dov IZ, Silver J et al. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int 2010; 77: 211-218.
49. Zanchi C, Locatelli M, Benigni A et al. Renal expression of FGF23 in progressive renal disease of diabetes and the effect of Ace inhibitor. PLoS One 2013; 8: e70775.
50. Pathare G, Fö ller M, Michael D et al. Enhanced FGF23 serum concentrations and phosphaturia in gene targeted mice expressing WNKresistant SPAK. Kidney Blood Press Res 2012; 36: 355-364.
51. Pathare G, Fö ller M, Daryadel A et al. OSR1-sensitive renal tubular phosphate reabsorption. Kidney Blood Press Res 2012; 36: 149-161.
52. Piontek KB, Huso DL, Grinberg A et al. A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. J Am Soc Nephrol 2004; 15: 3035-3043.
53. Brodehl J, Krause A, Hoyer PF. Assessment of maximal tubular phosphate reabsorption: comparison of direct measurement with the nomogram of Bijvoet. Pediatr Nephrol 1988; 2: 183-189.
54. Biber J, Stieger B, Haase W et al. A high yield preparation for rat kidney brush border membranes. Different behaviour of lysosomal markers. Biochim Biophys Acta 1981; 647: 169-176.
55. Biber J, Stieger B, Stange G et al. Isolation of renal proximal tubular brushborder membranes. Nat Protoc 2007; 2: 1356-1359.
56. Custer M, Lö tscher M, Biber J et al. Expression of Na-P(i) cotransport in rat kidney: localization by RT-PCR and immunohistochemistry. Am J Physiol 1994; 266: F767-F774.
57. Hilfiker H, Hattenhauer O, Traebert M et al. Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci USA 1998; 95: 14564-14569.